DryShips (DRYS) Halted on LUDP
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
DryShips (DRYS) Continues Parabolic Run; Shares up 94%
November 15, 2016 1:00 PM ESTDryShips (NASDAQ: DRYS) continues its parabolic run. Shares are now up 94%
... MoreDryShips (DRYS) Shares Tick to Session Highs
November 15, 2016 11:54 AM ESTDryShips (NASDAQ: DRYS) shares are moving to session highs. The stock is now up just under 60 percent on the session.
... MoreDryShips (DRYS) Halted Again LUDP
November 15, 2016 10:34 AM ESTDryShips (NASDAQ: DRYS) halted again on LUDP. Last up 25%. Shares saw whipsaw trading in a fast market upon resumption with the last halt. Longs took profits then shorts scrambled to cover
... MoreUnusual 11 Mid-Day Movers 11/14: (CRBP) (DRYS) (HAR) Higher; (DVAX) (RSO) (HEAR) Lower
November 14, 2016 1:09 PM ESTCorbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) 65.9% HIGHER; announced positive topline results from its Phase 2 study evaluating Resunab ("JBT-101") for the treatment of diffuse cutaneous systemic sclerosis. JBT-101 out-performed placebo in the American College of Rheumatology (ACR) Combined Response Index in diffuse cutaneous Systemic Sclerosis (CRISS) score, reaching 33% at week 16, versus 0% for placebo. The higher the CRISS score the greater the improvement; a CRISS score = 20% (CRISS20) can be considered a medically meaningful improvement
Dynavax Technologies Corporation (Nasdaq: DVAX) 63.2%... More